YSOPIA Bioscience

YSOPIA Bioscience Provides Gut Microbiota-Directed Therapeutics for Obesity and Related Cardiometabolic Disorders. The company’s drugs contain living organisms such as bacteria, treating obesity and metabolic disorders through their effects on the gut microbiota and intestinal mucosa, enabling healthcare companies to access innovative microbiome-based therapies.